Englewood Lab Valuation
Is A950140 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
1/6Valuation Score 1/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of A950140 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: A950140 (₩12310) is trading above our estimate of fair value (₩39.51)
Significantly Below Fair Value: A950140 is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for A950140?
Other financial metrics that can be useful for relative valuation.
What is A950140's n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | ₩244.57b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 1.1x |
Enterprise Value/EBITDA | 7.4x |
PEG Ratio | n/a |
Price to Earnings Ratio vs Peers
How does A950140's PE Ratio compare to its peers?
Company | Forward PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 9.1x | ||
A092130 e-Credible | 11.3x | 3.8% | ₩153.3b |
A030190 NICE Information Service | 9.3x | 9.3% | ₩575.4b |
A072990 HCT | 8.9x | 15.2% | ₩72.2b |
A130580 Nice D&B | 6.9x | 6.1% | ₩76.1b |
A950140 Englewood Lab | 11x | n/a | ₩244.6b |
Price-To-Earnings vs Peers: A950140 is expensive based on its Price-To-Earnings Ratio (11x) compared to the peer average (9.2x).
Price to Earnings Ratio vs Industry
How does A950140's PE Ratio compare vs other companies in the Asian Professional Services Industry?
Price-To-Earnings vs Industry: A950140 is good value based on its Price-To-Earnings Ratio (11x) compared to the Asian Professional Services industry average (20.3x).
Price to Earnings Ratio vs Fair Ratio
What is A950140's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 11x |
Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate A950140's Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.